title: The treatment of cerebrospinal fluid shunt infections. Results from a practice survey of the American Society of Pediatric Neurosurgeons.
abstract: It is our impression that the management strategy for infected cerebrospinal fluid (CSF) shunts varies significantly among pediatric neurosurgeons. The purpose of this paper is to present the results of a practice survey on the treatment of shunt infections which was distributed to all active members of the American Society of Pediatric Neurosurgeons (ASPN). Eighty-four of 129 ASPN members (65%) responded to the survey. Most ASPN members remove the shunt and place an external ventricular drain (EVD) to treat Staphylococcus epidermidis (59.5%), S. aureus (64.3%) and gram-negative rod infections (67.9%). The second most common method of treatment was externalization of the shunt (33.3, 29.8 and 25%, respectively). The duration of antibiotic treatment was extremely variable. When the shunt was removed and an EVD inserted, the duration of antibiotic treatment for S. epidermidis and S. aureus ranged from 5 to 21 total days (2-21 days of sterile cultures). For gram-negative rod infections treated with shunt removal and an EVD, the total duration of antibiotic therapy ranged from 5 to 24 days (2-37 days of sterile cultures). The majority of ASPN members remove the infected CSF shunt and place an EVD for the management of shunt infections. Significant variation exists in the duration of antibiotic therapy. Determining the most effective duration of antibiotic therapy in an effort to shorten hospitalization and minimize complications without sacrificing efficacy will require further study.
authors.affiliation: Department of Neurosurgery, University of Utah School of Medicine, Salt Lake City, Utah, USA.
authors.forename: W E
authors.initials: WE
authors.lastname: Whitehead
authors.forename: J R
authors.initials: JR
authors.lastname: Kestle
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D002557:Cerebrospinal Fluid Shunts; D003131:Combined Modality Therapy; D019091:Critical Pathways; D003625:Data Collection; D004334:Drug Administration Schedule; D006092:Gram-Negative Facultatively Anaerobic Rods; D006801:Humans; D007223:Infant; D008297:Male; D008826:Microbial Sensitivity Tests; D016459:Prosthesis-Related Infections / Q000601:surgery*; D013203:Staphylococcal Infections / Q000601:surgery; D013211:Staphylococcus aureus; D013212:Staphylococcus epidermidis; D013530:Surgical Wound Infection / Q000601:surgery*; D014696:Ventriculostomy
chemical_list: D000900:Anti-Bacterial Agents